Drug Delivery in Respiratory Diseases: Current Opportunities, Molecular and Cellular Mechanism, and Future Challenges

DG Dastidar, D Ghosh, S Ghosh… - … Signalling Pathways in …, 2021 - Springer
Respiratory diseases are a major cause of concern throughout the world. Lung cancer,
chronic obstructive pulmonary disease (COPD), and asthma deserve special mention …

An introduction to respiratory diseases and an emerging need for efficient drug delivery systems

K Sunkara, M Mehta, S Satija, DS Dhanjal… - Advanced Drug Delivery …, 2022 - Springer
Respiratory diseases, both acute or chronic and infectious or non-infectious, affect millions
of people worldwide. The leading causes of morbidity and mortality due to respiratory …

Nanoparticle-Based Lung Drug Delivery: A Clinical Perspective

V Shah, J Shah - Handbook of Lung Targeted Drug Delivery …, 2021 - api.taylorfrancis.com
Lung diseases consist of wide variety of deadly and obstinate diseases, such as chronic
obstructive pulmonary disease (COPD), asthma, lung cancer, idiopathic pulmonary fibrosis …

[HTML][HTML] Pulmonary delivery: innovative approaches and perspectives

C Marianecci, L Di Marzio, F Rinaldi, M Carafa… - Journal of biomaterials …, 2011 - scirp.org
The respiratory system, as well as the skin, are organs in direct contact with the environment
and it they represent possible doors for the entrance of therapeutic agents into the body …

Novel drug delivery systems and significance in respiratory diseases

B Mishra, J Singh - Targeting chronic inflammatory lung diseases using …, 2020 - Elsevier
Pulmonary drug delivery offers targeted therapy for the treatment of respiratory diseases
such as asthma, lung cancer, and chronic obstructive pulmonary diseases. However, this …

Nanostructures for Overcoming the Pulmonary Barrier: Drug Delivery Strategies

F Sonvico, F Buttini - 2012 - books.rsc.org
The administration of active substances to lungs via aerosols has steadily attracted the
interest of clinicians and pharmaceutical scientists thanks to the characteristics of this …

Targeting Chronic Lung Diseases Using Advanced Drug Delivery Systems

H Gandhi, S Mahant, A Bansal, DN Kapoor - Targeting Cellular Signalling …, 2021 - Springer
Targeting chronic lung diseases using advanced drug delivery systems explores the
development of novel therapeutics and diagnostics to improve pulmonary disease …

Patented therapeutic drug delivery strategies for targeting pulmonary diseases

AK Thakur, DK Chellappan, K Dua… - Expert opinion on …, 2020 - Taylor & Francis
Introduction: Pulmonary route is one of the preferred routes for the administration of
therapeutically active agents for systemic as well as localized delivery. Chronic obstructive …

Nanomedicine for the Management of Pulmonary Disorders

P Patowary, MP Pathak… - Handbook of Lung …, 2021 - api.taylorfrancis.com
The National Nanotechnology Initiative defines nanotechnology as the control and
understanding of matter at dimensions between approximately 1 and 100 nm, where unique …

Nanodelivery in airway diseases: challenges and therapeutic applications

I Roy, N Vij - Nanomedicine: Nanotechnology, Biology and Medicine, 2010 - Elsevier
This review describes the challenges and therapeutic applications of nanodelivery systems
for treatment of airway diseases. Therapeutic applications of nanodelivery in airway …